TABLE 1.

Case history of patients with OXA-23-producing A. baumannii^e

Isolate no.	Date of hospitalization (mo/day/yr)	Age (yr)	Sex	Ward	Date of isolation (mo/day/yr)	Underlying condition	Site of isolation	Diagnosisa	Treatmentb	Outcomec	PFGE pulsotypef
1	03/03/04	44	F	Gastroenterology	03/22/04	Heart failure	Rectal swab	C			A1
2	03/05/04	58	M	Cardiology ICU	03/22/04	Heart failure	Central catheter	Infection			A6
3	02/15/04	45	F	ICU	04/10/04	Asthma	Tracheal aspiration	Infection	AM, CS	Deceased	A1
4	03/28/04	50	M	ICU	04/13/04	Respiratory failure	Rectal swab	C			A6
5	02/09/04	62	M	Internal medicine	04/14/04	Paraplegia	Rectal swab	C			A6
6	04/10/04	22	M	ICU	04/20/04	Polytraumatism	Rectal swab	C			A6
7	03/31/04	39	M	Surgery	04/19/04	Arthritis	Rectal swab	C			A6
8	04/08/04	79	M	Internal medicine	04/20/04	Cerebral vascular	Urinary	Infection			A1
9	04/06/04	35	F	Endocrinology	04/22/04	Diabetes	Urinary	Infection			A5
10	03/23/04	68	F	ICU	04/22/04	Heart failure	Catheter	Infection			A4
11	03/28/04	61	M	ICU	04/23/04	Tetraplegia	Catheter	C			A4
12	08/30/03	58	M	Internal medicine	04/23/04	Tetraplegia	Rectal swab	C			A3
13	04/03/04	76	M	Internal medicine	04/26/04	Erysipelas	Rectal swab	C			A3
14	04/20/04	30	M	ICU	04/27/04	Respiratory failure	Rectal swab	C			A4
15	03/16/04	20	M	Gastroenterology	05/02/04	Leptospirosis	Rectal swab	C			A1
16	04/16/04	50	F	ICU	05/04/04	Meningitis	Rectal swab	C			A5
17	04/28/04	43	F	Emergency	05/04/04	Erysipela	Rectal swab	C			A1
18	05/02/04	8	F	Surgery	05/10/04	Polytraumatism	Rectal swab	C			A5
19	05/05/04	80	M	ICU	05/11/04	Cellulitis	Rectal swab	C			A2
20	03/14/04	77	M	Internal medicine	05/12/04	Cellulitis	Rectal swab	C			A1
21	04/13/04	67	M	Pneumology	05/14/04	Leukemia	BAFd	C			A3
22	05/01/04	66	M	Surgery	05/18/04	Digestive bleeding	Rectal swab	C			A1
23	04/21/04	76	M	ICU	05/19/04	Respiratory failure	Central catheter	C			A3
24	05/09/04	59	M	ICU	06/01/04	Epilepsy	Urinary catheter	C			A3

^aInfection or colonization (C) status was established based on clinical data.

^bOnly patients that received antibiotic treatment for their A. baumannii infections are shown. The treatment consisted of amikacin (AM) and colymicine (CS).

^cUnless-specified, the outcome was favorable with respect to the A. baumannii infection.

^dBAF, bronchoalveolar fluid.

^eAll isolates were imipenem resistant and positive for bla_OXA-23 by PCR. ICU, intensive care unit.

^fPulsotypes are according to Tenover et al. (20).